Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00302133 · ClinicalTrials.gov registry record · Phase 1
Optimizing Pharmacotherapy for Bipolar Alcoholics
A Phase 1 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 1
- Development phase
- 88
- Enrollment target
NCT00302133 is a Phase 1 study that has completed, run by University of Miami. The registered enrollment target is 88 participants.
The verdict
NCT00302133, a Phase 1 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 88 participants
- Enrollment target
Study Summary
The purpose of this study is to test the efficacy of naltrexone and valproate in the treatment of comorbid bipolar disorder and alcohol dependence.
Interventions
- OTHER Placebo
- DRUG Naltrexone hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2006-05 |
| Est. Completion | 2013-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00302133
The ClinicalTrials.gov registry entry for NCT00302133 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00302133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00302133 about?
NCT00302133 is a clinical study titled "Optimizing Pharmacotherapy for Bipolar Alcoholics". The purpose of this study is to test the efficacy of naltrexone and valproate in the treatment of comorbid bipolar disorder and alcohol dependence.
What is the current status of trial NCT00302133?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2006-05. Estimated completion is 2013-07.
What interventions are being tested in trial NCT00302133?
The interventions under investigation include: Placebo (OTHER), Naltrexone hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00302133?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.